Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial

2012/04/08 by Marion Cortet, M. Cortet, Catherine Deneux‐Tharaux +8 · 25 citations
Medicine · #Trauma, Hemostasis, Coagulopathy, Resuscitation #Blood properties and coagulation #Maternal and fetal healthcare

paper · doi:10.1093/bja/aes096

Citations

• Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model

Cited by

• Alternatives to blood transfusion. [europepmc]
• Transfusion and coagulation management in major obstetric hemorrhage. [europepmc]
• Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial. [europepmc]
• Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. [europepmc]
• Management of postpartum haemorrhage. [europepmc]
• National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review. [europepmc]
• Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings. [europepmc]
• Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial. [europepmc]
• TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial. [europepmc]
• Fibrinogen for the management of critical obstetric hemorrhage. [europepmc]
• Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study. [europepmc]
• Functional fibrinogen (FLEV-TEG) versus the Clauss method in an obstetric population: a comparative study. [europepmc]
• Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion. [europepmc]
• Coagulopathies in Pregnancy: What an Obstetrician Ought to Know! [europepmc]
• Effect of early cryoprecipitate transfusion versus standard care in women who develop severe postpartum haemorrhage (ACROBAT) in the UK: a protocol for a pilot cluster randomised trial. [europepmc]
• Prevention and treatment of postpartum hemorrhage: focus on hematological aspects of management. [europepmc]
• Coagulation abnormalities and bleeding in pregnancy: an anesthesiologist's perspective. [europepmc]
• Effect of cryoprecipitate transfusion therapy in patients with postpartum hemorrhage: a retrospective cohort study. [europepmc]
• Paper-Based Lateral Flow Device for the Sustainable Measurement of Human Plasma Fibrinogen in Low-Resource Settings. [europepmc]
• Protease activities of vaginal Porphyromonas species disrupt coagulation and extracellular matrix in the cervicovaginal niche. [europepmc]
• Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial. [europepmc]
• Innovations in the prevention and treatment of postpartum hemorrhage: Analysis of a novel medicines development pipeline database. [europepmc]
• Fibrinogen for the prediction of severe maternal complications in placental abruption with fetal death after 24 weeks of gestation. [europepmc]
• Review of Current Insights and Therapeutic Approaches for the Treatment of Refractory Postpartum Hemorrhage. [europepmc]
• Thromboelastography as an early prediction method for hypofibrinogenemia in emergency department patients with primary postpartum hemorrhage. [europepmc]